LENZ Therapeutics (LENZ) Change in Inventory (2025 - 2026)

LENZ Therapeutics (LENZ) reported Change in Inventory of $889000.0 for Q1 2026, down 73.27% quarter-over-quarter from $3.3 million in Q4 2025.

LENZ Therapeutics (LENZ) Change in Inventory (2025 - 2026) Analysis & Trends

LENZ Therapeutics (LENZ) has 2 years of Change in Inventory data on file, last reported at $889000.0 in Q1 2026.

Change in Inventory for Q1 2026 came in at $889000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 million (changed N/A YoY), and the FY2025 annual result was $4.3 million, changed N/A from the prior year.
Change in Inventory declined to $889000.0 in Q1 2026 per LENZ's latest filing, from $3.3 million in the prior quarter.
Over five years, Change in Inventory peaked at $3.3 million in Q4 2025 and troughed at $889000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	51,468.00
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	97.70 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	LENZ Therapeutics	192.19 Mn	192.19 Mn	825,000.00	889,000.00

Download Data